These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8932584)

  • 1. Elevated soluble CD23 levels in the sera from patients with localized scleroderma.
    Sato S; Fujimoto M; Kikuchi K; Ihn H; Tamaki K; Takehara K
    Arch Dermatol Res; 1996 Feb; 288(2):74-8. PubMed ID: 8932584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD4 and CD8 in serum from patients with localized scleroderma.
    Sato S; Fujimoto M; Kikuchi K; Ihn H; Tamaki K; Takehara K
    Arch Dermatol Res; 1996 Jun; 288(7):358-62. PubMed ID: 8818182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
    Nagaoka T; Sato S; Hasegawa M; Ihn H; Takehara K
    J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibody in localised scleroderma.
    Sato S; Fujimoto M; Hasegawa M; Takehara K
    Ann Rheum Dis; 2003 Aug; 62(8):771-4. PubMed ID: 12860735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen specificity of antihistone antibodies in localized scleroderma.
    Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
    Arch Dermatol; 1994 Oct; 130(10):1273-7. PubMed ID: 7524451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.
    Ihn H; Yazawa N; Kubo M; Yamane K; Sato S; Fujimoto M; Kikuchi K; Soma Y; Tamaki K
    J Rheumatol; 2000 Mar; 27(3):698-702. PubMed ID: 10743811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma.
    Ihn H; Fujimoto M; Sato S; Kikuchi K; Igarashi A; Soma Y; Takehara K
    J Am Acad Dermatol; 1994 Oct; 31(4):591-5. PubMed ID: 7916356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum levels of IgE-binding factor/soluble CD23 in bullous pemphigoid.
    Furukawa F; Kumagai S; Sakamoto Y; Takigawa M; Imamura S
    J Dermatol Sci; 1994 Apr; 7(2):150-4. PubMed ID: 8060916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4.
    Chomarat P; Briolay J; Banchereau J; Miossec P
    Arthritis Rheum; 1993 Feb; 36(2):234-42. PubMed ID: 8431213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis.
    Massa M; Pignatti P; Oliveri M; De Amici M; De Benedetti F; Martini A
    Clin Exp Rheumatol; 1998; 16(5):611-6. PubMed ID: 9779313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma.
    Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
    J Am Acad Dermatol; 1994 Oct; 31(4):567-71. PubMed ID: 8089281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid factor isotypes in localized scleroderma.
    Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
    Clin Exp Dermatol; 2005 Jul; 30(4):405-8. PubMed ID: 15953082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases.
    Matsushita T; Hasegawa M; Matsushita Y; Echigo T; Wayaku T; Horikawa M; Ogawa F; Takehara K; Sato S
    Exp Dermatol; 2007 Feb; 16(2):87-93. PubMed ID: 17222220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Fc epsilon RII/CD23 in patients with autoimmune diseases and Epstein-Barr virus-related disorders: analysis by ELISA for soluble Fc epsilon RII/CD23.
    Yoshikawa T; Nanba T; Kato H; Hori K; Inamoto T; Kumagai S; Yodoi J
    Immunomethods; 1994 Feb; 4(1):65-71. PubMed ID: 8069529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to the heat-shock protein hsp73 in localized scleroderma.
    Fujimoto M; Sato S; Ihn H; Takehara K
    Arch Dermatol Res; 1995; 287(6):581-5. PubMed ID: 7487146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of soluble CD23 in sera from patients with infectious mononucleosis.
    Hashimoto S; Takei M; Gon Y; Sawada S; Maekawa N; Yodoi J; Takada K; Horie T
    J Med Virol; 1997 Dec; 53(4):384-7. PubMed ID: 9407387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
    Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
    J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 and soluble CD23 serum levels in asthmatic atopic children.
    Daher S; Santos LM; Solé D; De Lima MG; Naspitz CK; Musatti CC
    J Investig Allergol Clin Immunol; 1995; 5(5):251-4. PubMed ID: 8574430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.